Takeshi Hatanaka
Gunma Saiseikai Maebashi Hospital(JP)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment, Cholangiocarcinoma and Gallbladder Cancer Studies, Hepatitis C virus research, Cancer, Lipids, and Metabolism
Most-Cited Works
- → Percutaneous Ablation for Hepatocellular Carcinoma: Comparison of Various Ablation Techniques and Surgery(2018)174 cited
- → Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis(2022)128 cited
- → Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population(2022)126 cited
- → Epilepsy with Continuous Spike‐Waves During Slow Sleep and Its Treatment(1991)113 cited
- → Prognostic impact of C-reactive protein and alpha-fetoprotein in immunotherapy score in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a multicenter retrospective study(2022)77 cited
- → Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child‐Pugh class A or B liver function in real‐world clinical practice(2022)77 cited
- → Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience(2021)76 cited
- → Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial(2019)74 cited
- → Effectiveness and safety of atezolizumab-bevacizumab in patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysis(2023)57 cited
- → Lenvatinib for Hepatocellular Carcinoma: A Literature Review(2021)57 cited